1584-Stiffness and Senescence Drive Ferroptosis Resistance

Paper Talk · Sep 17, 2026 · 19m

This research article investigates how gemcitabine chemotherapy inadvertently fuels treatment resistance in pancreatic ductal adenocarcinoma by triggering cellular senescence. The authors demonstrate that senescent tumor cells release a specific secretory phenotype that activates fibroblasts, leading to a stiffened, fibrotic tumor environment. This mechanical change activates the Piezo1 ion channel, which drives a metabolic shift that protects cancer cells from oxidative damage and ferroptosis. Specifically, the study identifies the BRG1–NRF2–SLC7A11 signaling axis as a critical defense…